Patent · US Active

Antibody molecule-drug conjugates and uses thereof

US11890319B2 · kind B2 · utility

0Cited by

11References

23Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

Zachary Shriver · Winchester, US
Obadiah J. Plante · Beverly, US
Kai Li · Mountain View, US
Karthik Viswanathan · Waltham, US
James C. Delaney · Cambridge, US
Boopathy Ramakrishnan · Braintree, US
Andrew M. Wollacott · Boston, US

Key dates

Filing date	Jan 18, 2018
Grant date	Feb 6, 2024
Priority date	—
Expiry date	Mar 31, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.